JyotiSMayadevMD

Radiation Oncology • San Diego, CA

Associate Professor, Radiation Oncology, University of California San Diego School of Medicine

Join to view full profile

Dr. Mayadev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mayadev's full profile

Already have an account?

Office
200 W Arbor Dr
San Diego, CA 92103
Phone+1 800-926-8273

Education & Training

University of WashingtonResidency, Radiation Oncology, 2005 - 2009
Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterInternship, Internal Medicine, 2004 - 2005
Case Western Reserve University School of MedicineClass of 2004

Certifications & Licensure

OR State Medical License 2004 - Present
CA State Medical License 2009 - 2025
WA State Medical License 2007 - 2017
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
Completed
Phase 3
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer Start of enrollment: 2012 Oct 01
Completed
Phase 1
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer Start of enrollment: 2019 Jan 07
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update.
Emma C Fields, Walter R Bosch, Kevin V Albuquerque, Rohini Bhatia, Junzo Chino
Practical Radiation Oncology. 2024-11-13
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radia...
Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, Krishnan R Patel, Randall J Kimple
The Lancet. Oncology. 2024-10-01
Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
Lance C Moore, Fritz Ahern, Lingyi Li, Karoline Kallis, Kelly Kisling
Medical Physics. 2024-07-01

Press Mentions

UCSD Health Moores Cancer Center Saving Lives During Pandemic with Clinical TrialsJuly 24th, 2020
Sequential CRT, Immunotherapy Nets High PFS in Node-Positive Cervical CancerDecember 2nd, 2019
Advances in Endometrial Cancer TherapiesJune 25th, 2016